Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER.
| Image |  |
|---|---|
| Description | scientific article published on December 1992 |
| Author/s |
author: V. Craig Jordan |
| Publication date | December 1, 1992 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |